Published in Cancer Weekly, September 5th, 2000
"Patients with metastasized renal cell carcinoma have a poor prognosis with conventional therapies," stated C. Frohn and colleagues, Medical University of Lubeck, Germany. "The feasibility and safety of donating purified NK cells without additional cytokines were evaluated. In contrast to all previous studies, the NK cells were derived from allogenic donors."
Frohn et al. published the results of their study in the Journal of Immunotherapy ("Feasibility of the adoptive transfusion of allogenic...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.